DIFFERENTIAL SENSITIVITY TO LUNG TUMORIGENESIS FOLLOWING TRANSPLACENTAL EXPOSURE OF MICE TO POLYCYCLIC HYDROCARBONS, HETEROCYCLIC AMINES, AND LUNG TUMOR PROMOTERS

References

• Rice JM:Perinatal period and pregnancy:intervals of high risk for chemical carcinogens. Environ Health Pe rspect. 1979;29:23-27.
   Google Scholar
• Miller MS:Transplacental lung carcinogenesis:a pharmacogenetic mou se model for the modulatory role of cytochrome P4501A1 on lung cancer initiation. Chem Res Toxicol. 1994;7:471-481.
   Google Scholar
• Miller MS, Juchau MR, Guengerich FP, Nebert DW, Raucy JL:Drug metabolic enzymes in developmental toxicology. Fundam Appl Toxicol. 1996;34:165-175.
   Google Scholar
• Stjernfeldt M, Berglund K, Lindsten J, Ludvigsson J:Maternal smoking during pregnancy and risk of childhood cancer. Lancet. 1986;1:1350-1352.
   Google Scholar
• John EM, Savitz DA, Sandler DP:Prenatal exposure to parents’smoking and childhood cancer. Am J Ep idemiol. 1991;133:123-132.
   Google Scholar
• Bunin GR, Kuijten RR, Buckley JD, Rorke LB, Meadows AT:Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. NEngl J Med. 1993;329:536-541.
   Google Scholar
• Whyatt RM, Garte SJ, Cosma G, Bell DA, Jedrychowski W, Wahrendorf J, et al:CYP1A1 messenger RNA levels in placental tissue as a biomarker of environmental exposure. Cancer Epidemiol Biomarkers Preven. 1995;4:147-153.
   Google Scholar
• Whyatt RM, Perera FP:Application of biologic markers to studies of environmental risks in children and the developing fetus. Environ Health Pe rspect. 1995;103 (Suppl 6):105-110.
   Google Scholar
• Parker SL, Tong T, Bolden S, Wingo PA:Cancer statistics. CACancer J Clin. 1997;47:5-27.
   Google Scholar
• Alberg AJ, Samet JM:Epidemiology of lung cancer. In:Kane MA, Bunn PAJr, eds. Biology of Lung Cancer. New York:Marcel Dekker; 1998:11-51.
   Google Scholar
• Anderson LM, Jones AB, Riggs CW, Ohshima M:Fetal mou se susceptibility to transplacental lung and liver carcinogenesis by 3-methylcholanthrene:positive correlation with responsiveness to inducers of aromatic hydrocarbon metabolism. Carcinogenesis. 1985;6:1389-1393.
   Google Scholar
• Wessner LL, Fan M, Schaeffer DO, McEntee MF, Miller MS:Mouse lung tumors exhibit specific Ki-ras mutations following transplacental exposure to 3-methylcholanthrene. Carcinogenesis. 1996;17:1519-1526.
   Google Scholar
• Miller MS, Jones AB, Park SS, Anderson LM:The formation of 3-methylcholanthrene-initiated lung tumors correlates with induction of cytochrome P450IA1 by the carcinogen in fetal but not adult mice. Toxicol Appl Pharmacol. 1990;104:235-245.
   Google Scholar
• Miller MS, Jones AB, Chauhan DP, Anderson LM:Role of the maternal environment in determining susceptibility to transplacentally induced chemical carcinogenesis in mouse fetu ses. Carcinogenesis. 1990;11:1979-1984.
   Google Scholar
• Miller MS, Jones AB, Chauhan DP, Park SS, Anderson LM:Differential induction of fetal mouse liver and lung cytochromes P-450 by beta-naphtho fl avone and 3-methylcholanthrene. Carcinogenesis. 1989;10:875-891.
   Google Scholar
• Thomas PE, Kouri RE, Hutton JJ:The genetics of aryl hydrocarbon hydroxylase induction in mice:a single gene difference between C57BL-6J and DBA-2J. Biochem Genet. 1972;6:157-168.
   Google Scholar
• Gielen JE, Goujon FM, Nebert DW:Genetic regulation of aryl hydrocarbon hydroxylase induction. II. Simple Me ndelian expression in mouse tissues in viv o. J Biol Ch em. 1972;247:1125-1137.
   Google Scholar
• Raucy JL, Carpenter SJ:The expression of xenobiotic-metabolizing cytochromes P450 in fetal tissues. J Pharmacol Toxicol Methods. 1993;29:121-128.
   Google Scholar
• Borlakoglu JT, Scott A, Henderson CJ, Wolf CR:Expression of P450 isoenzymes during rat liver organogenesis. Int J Biochem. 1993;25:1659-1668.
   Google Scholar
• Chauhan DP, Miller MS, Owens IS, Anderson LM:Gene expression, ontogeny and transplacental induction of hepatic UDP-glucuronosyl transferase activity in mice. Develop Pharmacol Ther. 1991;16:139-149.
   Google Scholar
• Kahn S, Yamamoto F, Almoguera C, Winter E, Forrester K, Jordano J, et al:The c-K-ras gene and human cancer. Anticancer Res. 1987;7:639-652.
   Google Scholar
• Carbone DP, Minna JD:The molecular genetics of lung cancer. Adv Intern Me d. 1992;37:153-171.
   Google Scholar
• Reynolds SH, Wiest JS, Devereux TR, Anderson MW, You M:Protoonco gene activation in spontaneously occurring and chemically induced rodent and human lung tumors. In:Klein-Szanto AJP, Anderson MW, Barrett JC, Slaga TJ, eds. Comparative Molecular Carcinogenesis. New York:Wiley-Liss; 1992:303-320.
   Google Scholar
• Rodenhuis S, van de Wetering ML, Mooi WJ, Evers SG,van Zandwijk N, Bos JL:Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. NEngl J Med. 1987;317:929-935.
   Google Scholar
• Rodenhuis S, Slebos RJ, Boot AJ, Evers SG, Mooi WJ,van Wagenaar SS, et al:Incidence and possible clinical signifi cance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res. 1988;48:5738-5741.
   Google Scholar
• Reynolds SH, Anna CK, Brown KC, Wiest JS, Beattie EJ, Pero RW, et al:Activated protoon cogenes in human lung tumors from smokers. Proc Natl Acad Sci US A. 1991;88:1085-1089.
   Google Scholar
• Slebos RJ, Hruban RH, Dalesio O, Mooi WJ, Offerhaus GJ, Rodenhuis S:Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. J Natl Cancer Inst. 1991;83:1024-1027.
   Google Scholar
• Mills NE, Fishman CL, Rom WN, Dubin N, Jacobson DR:Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res. 1995;55:1444-1447.
   Google Scholar
• Mitsudomi T, Steinberg SM, Oie HK, Mulshine JL, Phelps R, Viallet J, et al:ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. Cancer Res. 1991;51:4999-5002.
   Google Scholar
• Sugio K, Ishida T, Yokoyama H, Inoue T, Sugimachi K, Sasazuki T:ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Cancer Res. 1992;52:2903-2906.
   Google Scholar
• Rosell R, Li S, Skacel Z, Mate JL, Maestre J, Canela M, et al:Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients. Oncogene. 1993;8:2407-2412.
   Google Scholar
• Keohavong P, DeMichele MA, Melacrinos AC, Landreneau RJ, Weyant RJ, Siegfried JM:Detection of K-ras mutations in lung carcinomans:relationship to prognosis. Clin Cancer Res. 1996;2:411-418.
   Google Scholar
• Leone-Kabler SL, Wessner LL, McEntee MF, D’Agostino RB, Miller MS:Ki-ras mutations are an early event and correlate with tumor stage in transplacentally-induced murine lung tumors. Carcinogenesis. 1997;18:1163-1168.
   Google Scholar
• Gressani KM, Rollins LA, Leone-Kabler SL, Cline JM, Miller MS:Induction of mutations in Ki-ras and INK4a in liver tumors of mice exposed in utero to 3-methylcholanthrene. Carcinogenesis 1998;19:1045-1052.
   Google Scholar
• Wei SJ, Chang RL, Wong CQ, Bhachech N, Cui XX, Hennig E, et al:Dose-dependent differences in the profi le of mutations induced by an ultimate carcinogen from benzo[a] pyrene. Proc Natl Acad Sci US A. 1991;88:11227-11230.
   Google Scholar
• Hennig EE, Conney AH, Wei SJ:Characterization of hprt splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a] pyrene in Chinese hamster V-79 cells. Cancer Res. 1995;55:1550-1558.
   Google Scholar
• Wei SJ, Chang RL, Bhachech N, Cui XX, Merkler KA, Wong CQ, et al:Dose-dependent differences in the profi le of mutations induced by (1)-7R, 8S-dihydroxy-9S, 10R-epoxy-7, 8, 9, 10-tetrahydrobenzo(a) pyrene in the coding region of the hypoxanthine (guanine) phosphoribosyl-transferase gene in Chinese hamster V-79 cells. Cancer Res. 1993;53:3294-3301.
   Google Scholar
• Malkinson AM:The genetic basis of susceptibility to lung tumors in mice. Toxicology. 1989;54:241-271.
   Google Scholar
• Witschi H:Modulation of lung tumor development in rats, hamsters and mice. Prog Exp Tumor Res. 1991;33:132-153.
   Google Scholar
• Ryan J, Barker PE, Nesbitt MN, Ruddle FH:KRAS2 as a genetic marker for lung tumor susceptibility in inbred mice. J Natl Cancer Inst. 1987;79:1351-1357.
   Google Scholar
• Lin L, Festing MF, Devereux TR, Crist KA, Christiansen SC, Wang Y, et al:Additional evidence that the K-ras protoonco gene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. Exp Lung Res. 1998;24:481-497.
   Google Scholar
• Massey TE, Devereux TR, Maronpot RR, Foley JF, Anderson MW:High frequency of K-ras mutations in spontaneous and vinyl carbamate-induced lung tumors of relatively resistant B6CF1 (C57BL/6JBALB/cJ) mice. Carcinogenesis. 1995;16:1065-1069.
   Google Scholar
• Chen B, Johanson L, Wiest JS, Anderson MW, You M:The second intron of the K-ras gene contains regulatory elements associated with mouse lung tumor susceptibility. Proc Natl Acad Sci US A. 1994;91:1589-1593.
   Google Scholar
• Fijnemann RJ, Ophoff RA, Hart AA, Demant P:Kras-2 alleles, mutations, and lung tumor susceptibility in the mou se —an evaluation. Oncogene. 1994;9:1417-1421.
   Google Scholar
• Malkinson AM, Koski KM, Evans WA, Festing MF:Butylated hydroxytoluene exposure is necessary to induce lung tumors in BALB mice treated with 3-methylcholanthrene. Cancer Res. 1997;57:2832-2834.
   Google Scholar
• Gressani KM, Leone-Kabler SL, O’Sullivan MG, Case LD, Malkinson AM, Miller MS:Strain-specific lung tumor formation in mice transplacentally exposed to 3-methylcholanthrene and post-natally exposed to butylated hydroxytoluene. Carcinogenesis. 1999;20:2159-2165.
   Google Scholar
• Osborne MR, Brookes P, Lee HM, Harvey RG:The reaction of a 3-methylcholanthrene diol epoxide with DNA in relation to the binding of 3-methylcholanthrene to the DNA of mammalian cells. Carcinogenesis. 1986;7:1345-1350.
   Google Scholar
• Horio Y, Chen A, Rice P, Roth JA, Malkinson AM, Schrump DS:Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice. Mol Carcinog. 1996;17:217-223.
   Google Scholar
• Nuzum EO, Malkinson AM, Beer DG:Specific Ki-ras codon 61 mutations may determine the development of urethan-induced mouse lung adenomas or adenocarcinomas. Mol Carcinog. 1990;3:287-295.
   Google Scholar
• Matzinger SA, Gunning WT, You M, Castonguay A:Ki-ras mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-initiated and butylated hydroxytoluene-promoted lung tumors in A/J mice. Mol Carcinog. 1994;11:42-48.
   Google Scholar
• Rehm S, Ward JM, ten Have-Opbroek AA, Anderson LM, Singh G, Katyal SL, et al:Mouse papillary lung tu mors transplacentally induced by N-nitrosoethylurea:evidence for alveolar type II cell origin by comparative light microscopic, ultrastructural, and immunohistochemical studies. Cancer Res. 1988;48:148-160.
   Google Scholar
• Branstetter DG, Stoner GD, Budd C, Conran PB, Goldblatt PJ:Effect of gestational development of lung tumor size and morphology in the mouse. Cancer Res. 1988;48:379-386.
   Google Scholar
• Greenblatt MS, Bennett WP, Hollstein M, Harris CC:Mutations in the p53 tu mor suppressor gene:clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994;54:4855-4878.
   Google Scholar
• Hainaut P, Soussi T, Shomer B, Hollstein M, Greenblatt M, Hovig E, et al:Database of p53 gene somatic mutations in hu man tumors and cell lines:updated compilation and future prospects. Nucleic Acids Res. 1997;25:151-157.
   Google Scholar
• Hainaut P, Hernandez-Boussard TM:A specific spectrum of p53 mutations in lung cancer from smokers:review of mutations compiled in the IARC p53 database. Environ Health Pe rspect. 1998;106:385-391.
   Google Scholar
• Miller MS:Tumor suppressor genes in rodent lung carcinogenesis —mutation of p53 does not appear to be an early lesion in lung tumor pathogenesis. Toxicol Appl Pharmacol. 1999;156:70-77.
   Google Scholar
• Weinberg RA:The retinoblastom a protein and cell cycle control. Ce ll. 1995;81:323-330.
   Google Scholar
• Okamoto A, Demetrick DJ, Spillare EA, Hagiwara K, Hussain SP, Bennett WP, et al:Mu tations and altered expression of p16INK 4 in hu man cancer. Proc Natl Acad Sci US A. 1994;91:11045-11049.
   Google Scholar
• Sherr CJ:Cancer cell cycles. Science. 1996;274:1672-1677.
   Google Scholar
• Otterson GA, Kratzke RA, Coxon A, Kim YW, Kaye FJ:Absence of p16INK 4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene. 1994;9:3375-3378.
   Google Scholar
• Shapiro GI, Edwards CD, Kobzik L, Godleski J, Richards W, Sugarbaker DJ, et al:Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res. 1995;55:505-509.
   Google Scholar
• Kratzke RA, Greatens TM, Rubins JB, Maddaus MA, Niewoehner DE, Niehans GA, et al:Rb and p16INK4a expression in resected non-small cell lung tumors. Cancer Res. 1996;56:3415-3420.
   Google Scholar
• Rollins LA, Leone-Kabler SL, O’Sullivan MG, Miller MS:Role of tumor suppressor genes in transplacental lung carcinogenesis. Mol Carcinog. 1998;21:177-184.
   Google Scholar
• Miller MS, Leone-Kabler SL, Rollins LA, Wessner LL, Fan M, Schaeffer DO, McEntee MF, O’Sullivan MG:Molecular pathogenesis of transplacentally-induced mouse lung tumors. Exp Lung Res. 1998;24:557-577.
   Google Scholar
• Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, et al:The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBOJ. 1998;17:5001-5014.
   Google Scholar
• Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, et al:Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Ce ll. 1997;91:649-659.
   Google Scholar
• Swafford DS, Middleton SK, Palmisano WA, Nikula KJ, Tesfaigzi J, Baylin SB, et al:Frequent aberrant methylation of p16INK4a in primary rat lung tumors. Mol Cell Biol. 1997;17:1366-1374.
   Google Scholar
• Otterson GA, Khleif SN, Chen W, Coxon AB, Kaye FJ:CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2’-deoxycytidine. Oncogene. 1995;11:1211-1216.
   Google Scholar
• Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, Gabrielson E, et al:Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci US A. 1998;95:11891-11896.
   Google Scholar
• Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, et al:Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 1995;55:4525-4530.
   Google Scholar
• Herzog CR, You M:Sequence variation and chromosom al mapping of the murine Cd kn 2a tumor suppressor gene. Mamm Genome. 1997;8:65-66.
   Google Scholar
• Zhang SL, Ramsay ES, Mock BA:CDKN2A, the cyclin-dependent kinase inhibitor encoding p16(INK4A) and p19(ARF), is a candidate for the plasmacytoma susceptibility locus, PCTR1. Proc Natl Acad Sci US A. 1998;95:2429-2434.
   Google Scholar
• Schut HA, Snyderwine EG:DNA adducts of heterocyclic amine food mutagens:implications for mutagenesis and carcinogenesis. Carcinogenesis. 1999;20:353-368.
   Google Scholar
• Sugimura T:Overview of carcinogenic hete rocyclic amines. Mutat Res. 1997;376:211-219.
   Google Scholar
• Ghoshal A, Snyderwine EG:Excretion of food-derived heterocyclic amine carcinogens into breast milk of lactating rats and formation of DNA adducts in the newborn. Carcinogenesis. 1993;14:2199-2203.
   Google Scholar
• Davis CD, Ghoshal A, Schut HA, Snyderwine EG:Me tabolism of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine by lactating Fischer 344 rats and their nu rsing pups. J Natl Cancer Inst. 1994;86:1065-1070.
   Google Scholar
• Mauthe RJ, Snyderwine EG, Ghoshal A, Freeman SP, Turteltaub KW:Distribution and metabolism of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) in female rats and their pups at dietary doses. Carcinogenesis. 1998;19:919-924.
   Google Scholar
• Brittebo EB, Karlsson AA, Skog KI, Jagerstad IM:Transfer of the food mutagen PhIP to foetuses and newborn mice following maternal exposure. Food Chem Toxicol. 1994;32:717-726.
   Google Scholar
• Dooley KL, Von Tungeln LS, Bucci T, Fu PP, Kadlubar FF:Comparative carcinogenicity of 4-aminobiphenyl and the food pyrolysates, Glu-P-1, IQ, PhIP, and MeIQx in the neonatal B6C3F1 male mouse. Cancer Lett. 1992;62:205-209.
   Google Scholar
• Paulsen JE, Steffensen IL, Andreassen A, Vikse R, Alexander J:Neonatal exposure to the food mutagen 2-amino-1-methyl-6-phenylimidazo[4, 5-b] pyridine via breast milk or directly induces intestinal tumors in multiple intestinal neoplasia mice. Carcinogenesis. 1999;20:1277-1282.
   Google Scholar
• Greenberg RS, Shuster JLJr.:Epidemiology of cancer in children. Epidemiol Rev. 1985;7:22-48.
   Google Scholar
• Turusov VS, Tomatis L:Transplacental and transgenerational carcinogenesis. Arkhiv Patologii. 1997;59:7-12.
   Google Scholar
• Ohgaki H, Kusama K, Matsukura N, Morino K, Hasegawa H, Sato S, et al:Carcinogenicity in mice of a mutagenic compound, 2-amino-3-methylimidazo[4, 5-f]quinoline, from broiled sardine, cooked beef and beef extract. Carcinogenesis 1984;5:921-924.
   Google Scholar
• Takayama S, Nakatsuru Y, Masuda M, Ohgaki H, Sato S, Sugimura T:Demonstration of carcinogenicity in F344 rats of 2-amino-3-methyl-imidazo[4, 5-f] quinoline from broiled sardine, fried beef and beef extract. Gann. 1984;75:467-470.
   Google Scholar
• Tanaka T, Barnes WS, Williams GM, Weisburger JH:Mu ltipotential carcinogenicity of the fried food mutagen 2-amino-3-methylimidazo[4, 5-f]quinoline in rats. Japn J Cancer Res. 1985;76:570-576.
   Google Scholar
• Boobis AR, Lynch AM, Murray S, de la Torre R, Solans A, Farre M, et al:CYP1A2-catalyzed conversion of dietary hete rocyclic amines to their proximate carcinogens is their major route of metabolism in hu mans. Cancer Res. 1994;54:89-94.
   Google Scholar
• Snyderwine EG, Battula N:Selective mutagenic activation by cytochrome P3-450 of carcinogenic arylamines found in foods. J Natl Cancer Inst. 1989;81:223-227.
   Google Scholar
• Minchin RF, Reeves PT, Teitel CH, McManus ME, Mojarrabi B, Ilett KF, et al:N- and O-acetylation of aromatic and hete rocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells. Biochem Biophys Res Commun. 1992;185:839-844.
   Google Scholar
• Yanagawa Y, Sawada M, Deguchi T, Gonzalez FJ, Kamataki T:Stable expression of human CYP1A2 and N-acetyltransferases in Chinese hamster CHL cells:mutagenic activation of 2-amino-3-methylimidazo[4, 5-f] quinoline and 2-amino-3, 8-dimethylimidazo[4, 5-f]quinoxaline. Cancer Res. 1994;54:3422-3427.
   Google Scholar
• Kimura S, Gonzalez FJ, Nebert DW:Tissue-specific expression of the mouse dioxin-inducible P(1) 450 and P(3) 450 genes:differential transcriptional activation and mRNA stability in liver and extrahepatic tissues. Mol Cell Biol. 1986;6:1471-1477.
   Google Scholar
• Adachi H, Degawa M, Miura S, Hashimoto Y, Sugimura T, Esumi H:Induction of putative new cytochrome P450 isozyme in rat liver by 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine. Biochem Biophys Res Commun. 1991;174:797-803.
   Google Scholar
• Boobis AR, Sesardic D, Murray BP, Edwards RJ, Davies DS:Specifi city and inducibility of cytochrome P-450 catalyzing the activation of food-derived mutagenic hete rocyclic amines. In:Hlavica P, Damani LA, eds. N-Oxidation of Drugs:Biochemistry, Pharmacology, Toxicology. London:Chapman and Hall; 1991:345-355.
   Google Scholar
• Crofts FG, Sutter TR, Strickland PT:Metabolism of 2-amino-1-methyl-6-phenylimidazo[4, 5-b] pyridine by human cytochrome P4501A1, P4501A2 and P4501B1. Carcinogenesis. 1998;19:1969-1973.
   Google Scholar
• Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, et al:Activation of chemically diverse procarcinogens by human cytochrome P-4501B1. Cancer Res. 1996;56:2979-2984.
   Google Scholar
• Tuteja N, Gonzalez FJ, Nebert DW:Developmental and tissue-specific differential regulation of the mouse dioxin-inducible P1-450 and P3-450 genes. Dev Biol. 1985;112:177-184.
   Google Scholar
• Kimura S, Donovan JC, Nebert DW:Expression of the mouse P(1) 450 gene during differentiation without foreign chemical stimulation. J Exp Pathol. 1987;3:61-74.
   Google Scholar
• Nebert DW, Gelboin HV:The in vivo and in vitro induction of aryl hydrocarbon hydroxylase in mammalian cells of different species, tissues, strains, and developmental and hormonal states. Arch Biochem Biophys. 1969;134:76-89.
   Google Scholar
• Dey A, Westphal H, Nebert DW:Cell-specific induction of mouse Cyp1a 1 mRNA during development. Proc Natl Acad Sci US A. 1989;86:7446-7450.
   Google Scholar
• Hakkola J, Pasanen M, Pelkonen O, Hukkanen J, Evisalmi S, Anttila S, et al:Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A 1 by Ah receptor ligands in hu man placenta and cultured cells. Carcinogenesis. 1997;18:391-397.
   Google Scholar
• Lin FH, Stohs SJ, Birnbaum LS, Clark G, Lucier GW, Goldstein JA:The effects of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) on the hepatic estrogen and glucocorticoid receptors in congenic strains of Ah responsive and Ah nonresponsive C57BL/6J mice. Toxicol Appl Pharmacol. 1991;108:129-139.
   Google Scholar
• Gressani KM, Leone-Kabler S, O’Sullivan GM, Townsend AJ, Miller MS:Prenatal toxicity and lack of carcinogenicity of 2-amino-3-methylimidazo[4, 5-f]quinoline (IQ) following transplacental exposure. Toxicol Sci. 2000;55:407-414.
   Google Scholar
• Eisenbrand G, Tang W:Food-borne heterocyclic amines. Chemistry, formation, occurrence and biological activities. A literature review. Toxicology. 1993;84:1-82.
   Google Scholar
• Kleman MI, Overvik E, Mason GG, Gustafsson JA:In vitro activation of the dioxin receptor to a DNA-binding form by food-borne heterocyclic amines. Carcinogenesis. 1992;13:1619-1624.
   Google Scholar
• Hasegawa R, Kimura J, Yaono M, Takahashi S, Kato T, Futakuchi M, et al:Increased risk of mammary carcinoma development following transplacental and trans-breast milk exposure to a food-derived carcinogen, 2-amino-1-methyl-6-phenylimidazo[4, 5-b] pyridine (PhIP), in Sprague-Dawley rats. Cancer Res. 1995;55:4333-4338.
   Google Scholar